Cardinal Health
807 hedge funds and large institutions have $22.4B invested in Cardinal Health in 2016 Q2 according to their latest regulatory filings, with 83 funds opening new positions, 313 increasing their positions, 303 reducing their positions, and 58 closing their positions.
43% more first-time investments, than exits
New positions opened: 83 | Existing positions closed: 58
2% more funds holding
Funds holding: 792 → 807 (+15)
1.7% more ownership
Funds ownership: 86.41% → 88.11% (+1.7%)
4% more call options, than puts
Call options by funds: $60.4M | Put options by funds: $58.2M
3% more repeat investments, than reductions
Existing positions increased: 313 | Existing positions reduced: 303
1% less capital invested
Capital invested by funds: $22.5B → $22.4B (-$128M)
7% less funds holding in top 10
Funds holding in top 10: 14 → 13 (-1)
Top Buyers
Top Sellers
| 1 |
Royal London Asset Management
United Kingdom
|
-$523M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$272M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
-$241M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$187M |
| 5 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$123M |
CAH Hedge Fund Activity: Q2 2016 in Review
807 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Cardinal Health (CAH) for Q2 2016, worth a combined $22.4B — down 0.57% from $22.5B a quarter earlier.
Buyers outnumbered sellers: 83 funds opened new CAH positions and 58 closed out — a net gain of 25 holders — while 313 added to existing stakes and 303 trimmed.
The largest buyer was Macquarie Group, adding an estimated $796M. The largest seller was Royal London Asset Management, cutting an estimated $523M.
- 807 institutional investors held Cardinal Health (CAH) as of Q2 2016, up from 792 in Q1 2016.
- Funds reported $22.4B of Cardinal Health stock for Q2 2016, down 0.57% quarter-over-quarter.
- 83 funds opened new Cardinal Health positions in Q2 2016 and 58 closed out, a net change of +25 holders.
- The largest Cardinal Health buyer in Q2 2016 was Macquarie Group, an estimated $796M added.
- The largest Cardinal Health seller in Q2 2016 was Royal London Asset Management, an estimated $523M sold.
Based on aggregated 13F filings for Q2 2016.